Soliris

­
  • Soliris

Soliris

Facts of Soliris 300mg (eculizumab) ?

  • Medicine Name: Soliris
  • Generic Name: eculizumab
  • Approval Date: September 23, 2011,
  • Company Name: Alexion, Inc
  • Available as (Form & Strength): For injectable suspension: lyophilized powder containing 100 mg of paclitaxel formulated as albumin-bound particles in single-use vial for reconstitution.
Category:

Product Description

What are the indications and usage?

Paroxysmal Nocturnal Hemoglobinuria (PNH): Soliris is indicated for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis

Atypical Hemolytic Uremic Syndrome (aHUS) : Soliris is indicated for the treatment of patients with atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy

Reviews

There are no reviews yet.

Be the first to review “Soliris”